| A comprehensive comparison of early-onset and average-onset colorectal cancers A Cercek, WK Chatila, R Yaeger, H Walch, GDS Fernandes, A Krishnan, ... JNCI: Journal of the National Cancer Institute 113 (12), 1683-1692, 2021 | 104 | 2021 |
| Response to anti-EGFR therapy in patients with BRAF non-V600–mutant metastatic colorectal cancer R Yaeger, D Kotani, S Mondaca, AR Parikh, H Bando, EE Van Seventer, ... Clinical Cancer Research 25 (23), 7089-7097, 2019 | 104 | 2019 |
| Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ... PLoS medicine 18 (3), e1003415, 2021 | 80 | 2021 |
| Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study JJ Harding, J Fan, DY Oh, HJ Choi, JW Kim, HM Chang, L Bao, HC Sun, ... The Lancet Oncology 24 (7), 772-782, 2023 | 63 | 2023 |
| Genomic Characterization of ERBB2-Driven Biliary Cancer and a Case of Response to Ado-Trastuzumab Emtansine S Mondaca, P Razavi, C Xu, M Offin, M Myers, M Scaltriti, JF Hechtman, ... JCO Precision Oncology 3, 1-9, 2019 | 37 | 2019 |
| Specific mutations in APC, but not alterations in DNA damage response, associate with outcomes of patients with metastatic colorectal cancer S Mondaca, H Walch, S Nandakumar, WK Chatila, N Schultz, R Yaeger Gastroenterology 159 (5), 1975-1978. e4, 2020 | 29 | 2020 |
| FOLFCIS treatment and genomic correlates of response in advanced anal squamous cell cancer S Mondaca, WK Chatila, D Bates, JF Hechtman, A Cercek, NH Segal, ... Clinical colorectal cancer 18 (1), e39-e52, 2019 | 25 | 2019 |
| Colorectal cancer genomics and designing rational trials S Mondaca, R Yaeger Annals of Translational Medicine 6 (9), 2018 | 24 | 2018 |
| SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study M Dib, N Le Corre, C Ortiz, D García, M Ferrés, C Martinez-Valdebenito, ... The Lancet Regional Health–Americas 16, 2022 | 22 | 2022 |
| High proportion of potential candidates for immunotherapy in a chilean cohort of gastric cancer patients: Results of the FORCE1 study M Cordova-Delgado, MP Pinto, IN Retamal, M Muñoz-Medel, ML Bravo, ... Cancers 11 (9), 1275, 2019 | 22 | 2019 |
| Early anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: a randomized phase II clinical trial ME Balcells, L Rojas, N Le Corre, C Martínez-Valdebenito, ME Ceballos, ... medRxiv, 2020.09. 17.20196212, 2020 | 21 | 2020 |
| Reduced immune response to inactivated severe acute respiratory syndrome coronavirus 2 vaccine in a cohort of immunocompromised patients in Chile ME Balcells, N Le Corre, J Durán, ME Ceballos, C Vizcaya, S Mondaca, ... Clinical Infectious Diseases 75 (1), e594-e602, 2022 | 20 | 2022 |
| Chilean Gastric Cancer Task Force: A study protocol to obtain a clinical and molecular classification of a cohort of gastric cancer patients GI Owen, MP Pinto, IN Retamal, MF Fernádez, B Cisternas, S Mondaca, ... Medicine 97 (16), e0419, 2018 | 20 | 2018 |
| Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile ME Balcells, N Le Corre, J Durán, ME Ceballos, C Vizcaya, S Mondaca, ... Clinical Infectious Diseases: An Official Publication of the Infectious …, 2022 | 19 | 2022 |
| Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions S Mondaca, ES Lebow, A Namakydoust, P Razavi, JS Reis-Filho, R Shen, ... Lung Cancer 159, 66-73, 2021 | 19 | 2021 |
| Metformin protects from oxaliplatin induced peripheral neuropathy in rats NW Martinez, A Sánchez, P Diaz, R Broekhuizen, J Godoy, S Mondaca, ... Neurobiology of Pain 8, 100048, 2020 | 18 | 2020 |
| Reduction in the number of early melanomas diagnosed during the COVID‐19 pandemic: a single‐centre cohort study E Koch, F Villanueva, MA Marchetti, Á Abarzúa‐Araya, C Cardenas, ... Journal of the European Academy of Dermatology and Venereology 35 (11), e735, 2021 | 17 | 2021 |
| Biliary tract cancer prognostic and predictive genomics S Mondaca, B Nervi, M Pinto, GK Abou-Alfa Chinese clinical oncology 8 (4), 42, 2019 | 17 | 2019 |
| Phase II study of trastuzumab with modified docetaxel, cisplatin, and 5 fluorouracil in metastatic HER2-positive gastric cancer S Mondaca, M Margolis, F Sanchez-Vega, P Jonsson, JC Riches, GY Ku, ... Gastric Cancer 22, 355-362, 2019 | 16 | 2019 |
| A molecular stratification of chilean gastric cancer patients with potential clinical applicability MP Pinto, M Córdova-Delgado, IN Retamal, M Muñoz-Medel, ML Bravo, ... Cancers 12 (7), 1863, 2020 | 15 | 2020 |
